Navigation Links
Expression Injectable by Enhancement Medical – Adverse Events: AttorneyOne Monitors and Keeps Consumers Informed
Date:8/8/2014

San Diego, CA (PRWEB) August 08, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Expression Injectable.

The FDA issued a safety communication on August 5, on adverse events associated with the unapproved use of the Expression product as a dermal filler. Expression is used as an intranasal splint, intended to minimize bleeding and swelling and to prevent adhesions between the septum and the nasal cavity.

FDA’s reason for the safety communication is that the Agency became aware of adverse events, related to unapproved use, that included itching, discoloration, redness, bruising, pain, bumps, lumps, firmness, tenderness, swelling, and the development of hard nodules.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds, “We are determined to keep an eye on FDA announcements concerning Expression Injectable and inform the public. For that reason," he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

The FDA recommends that “health care providers stop using Expression by Enhancement Medical LLC as a subcutaneously administered substance and instead use the list of FDA approved fillers.” And the Agency adds “patients who have received treatment with Expression as a dermal filler should be monitored for adverse events and referred for corrective treatment when appropriate.”

AttorneyOne.com has further information on Expression Injectable at the website including latest major drug, food, and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/08/prweb12077689.htm.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12081219.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Barriers to obtaining gene expression profiling test heightened perceived value
2. Overexpression of Notch1 in temporal lobe epilepsy
3. TAG-1 induces apoptosisrelated gene expression without triggering glioma apoptosis
4. Shuganjieyu capsule increases neurotrophic factor expression in a rat model of depression
5. Variable gene expression in zebrafish
6. Occludin and connexin 43 expression in the pathogenesis of traumatic brain edema
7. Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence
8. Researchers report a complete description of gene expression in the human retina
9. Advancement in Biologic Protein Expression Webinar Hosted by Selexis SA
10. Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence
11. McHugh Plastic Surgery & Secret Expressions Med Spa Offer Injection Day Specials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... ... 2016 , ... The Florida Hospital Tampa Wound Healing Institute ... (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute as ... facilities have earned this distinction. This is the second time the Florida Hospital ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... and JENNERSVILLE, Pa. (PRWEB) , ... December 08, ... ... that Penn Medicine Southern Chester County, a Property owned by an affiliate of ... million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... OSAKA, Japan , Dec. 9, 2016 ... ; President & Representative Director, CEO: Dr. ... with amyotrophic lateral sclerosis (ALS) given edaravone intravenously in ... functional loss as measured by the ALS Functional Rating ... th International Symposium on ALS/MND in ...
(Date:12/9/2016)... 9, 2016  Axovant Sciences Ltd. (NYSE: ... focused on the treatment of dementia, today announced ... Phase 2b trial evaluating treatment with intepirdine (RVT-101), ... donepezil plus placebo in people with mild-to-moderate Alzheimer,s ... intepirdine to treatment was associated with reduced progression ...
Breaking Medicine Technology: